Sort
8,912 grants matching “sars cov 2”
COVID-19 Vaccine Effectiveness in Pregnant Women and their Infants
$539,872Ousseny Zerbo · Kaiser Foundation Research Institute · R01 · FY2025 · AI
COVID-19 Vaccine Effectiveness in Pregnant Women and their Infants
$539,708Ousseny Zerbo · Kaiser Foundation Research Institute · R01 · FY2024 · AI
Beta cell dysfunction as an acute and a post acute sequelae of COVID19
$539,271Senta K Georgia · Children'S Hospital Of Los Angeles · R01 · FY2023 · DK
Placental origins of phthalate-induced changes in fetal reproductive development
$538,933Jennifer Joan Adibi · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · ES
Progesterone induced immune modulation during pregnancy â supplemental research in COVID-19
$538,121Sing Sing Way · Cincinnati Childrens Hosp Med Ctr · R01 · FY2022 · AI
Metabolism-based interactions and organ-targeted delivery of molnupiravir, nirmatrelvir and remdesivir
$537,517Bingfang Yan · University Of Cincinnati · R01 · FY2025 · AI
TOP3B as host factor and drug target for SARS-CoV-2 replicative cycle
$537,410Yves Pommier · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Addressing Vaccine AcceptaNce in Carceral Settings through Community Engagement (ADVANCE)
$537,272Lisa Balzano Puglisi · Yale University · R01 · FY2024 · MD
Molecular insights into the effects of SARS-Cov2 infection on the blood system
$536,871Naoko Mizuno · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
Statistical Methods for Efficacy Trials of Vaccines and Monoclonal Antibodies Against Genetically-Diverse Pathogens
$536,488Peter B. Gilbert · Fred Hutchinson Cancer Center · R37 · FY2024 · AI
Identification of senescent cell types
$535,846Laura Jane Niedernhofer · University Of Minnesota · P01 · FY2025 · AI
Risk of Viral Emergence from Bats
$535,156Peter Daszak · Ecohealth Alliance, Inc. · R01 · FY2009 · AI
NICHD Global Network for Womenâs and Childrenâs Health Research: Research Units
$535,093William A Petri · University Of Virginia · UG1 · FY2023 · HD
Development of multivalent, ultrapotent nanobody cocktails for SARS-CoV-2 neutralization
$535,044Yi Shi · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · AI
Influenza & COVID Obstetric and Perinatal Epidemiology Study in India
$534,998Patricia L Hibberd · Boston University Medical Campus · R01 · FY2023 · HD
Risk of Viral Emergence from Bats
$534,989Peter Daszak · Ecohealth Alliance, Inc. · R01 · FY2008 · AI
Deciphering long-term virus evolution through the reconstruction of past viral genomes
$534,762Daniel Blanco-Melo · Fred Hutchinson Cancer Center · DP2 · FY2023 · AI
The Impacts of Mitigation Strategies to Prevent COVID-19 Transmission in American Indian Communities
$534,652Randall K. Q. Akee · National Bureau Of Economic Research · R01 · FY2023 · MD
Brain Tissue Resource Center for Alcohol Research
$534,636Greg Trevor Sutherland · University Of Sydney · R28 · FY2023 · AA
Training Program in Substance Use, HIV and Related Infections
$534,562Natasha Martin · University Of California, San Diego · T32 · FY2022 · DA
Small Molecular Inactivators of HIV
$534,506Daniel H Appella · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK
Short-term and long-term impact of COVID-19 on multiple sensory systems
$534,389Kai Zhao · Ohio State University · R01 · FY2025 · DC
Impact of immune sex differences in the first 1000 days of life and in childhood and adolescence
$534,090Philip J Goulder · University Of Oxford · U01 · FY2023 · AI
Decoding multidrug-resistant pathogen dynamics for clinically-relevant wastewater surveillance
$534,000Medini K Annavajhala · Children'S Hosp Of Philadelphia · DP2 · FY2025 · AI
Global Research Endeavors to Advance Treatment of Neurological Disorders in Africa (GREAT Neurology)
$533,982Gretchen Lano Birbeck · University Of Rochester · R35 · FY2025 · NS